Kaposi sarcoma in a kidney transplant recipient

Autor: Sopiko Liluashvili, Salome Pataraia, George Galdava, Tinatin Ghibradze

Publikováno v: Przegląd Dermatologiczny, Vol 109, Iss 6, Pp 460-463 (2023)

We present the case report of a kidney transplant recipient, human immunodeficiency virus negative, man with Kaposi sarcoma. Clinically red-purple coloured papules and macules of different size were visible on the left foot. According to histopatholo

Externí odkaz: https://doaj.org/article/4e79b2cdd3eb4d98bdef6433d600fe50

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis:A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

Autor: Hendrik Otto, Grazyna Pulka, Külli Kingo, Roshan Dias, Fausto Berti, Richard Kay, Halimu N. Haliduola, Nataliya Reznichenko, Eric Guenzi, George Galdava, Steven R. Feldman, Joanna Sobierska, Heimo Stroissnig

Publikováno v: Feldman, S R, Reznichenko, N, Pulka, G, Kingo, K, George Galdava, Berti, F, Sobierska, J, Dias, R, Guenzi, E, Hendrik Otto, Haliduola, H N, Kay, R & Stroissnig, H 2021, ' Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis : A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study ', BioDrugs, vol. 35, no. 6, pp. 735-748 . https://doi.org/10.1007/s40259-021-00502-w
Biodrugs

Background AVT02 (adalimumab) is a proposed biosimilar to Humira®. AVT02 is produced at a 100 mg/mL concentration with a citrate-free formulation. Objectives The aim of this study was to compare the efficacy, safety and immunogenicity of AVT02 versu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9abf66f1bee2ff164778cbe7acdd210a
https://findresearcher.sdu.dk:8443/ws/files/195534959/Feldman2021_Article_EfficacySafetyAndImmunogenicit.pdf

Issues of management of Epidermolysis bullosa in Georgia

Autor: George Galdava, George Tvaliashvili, Oleg Kvlividze, Tamar Chigladze

Publikováno v: Orphanet Journal of Rare Diseases, Vol 5, Iss Suppl 1, p P28 (2010)
Orphanet Journal of Rare Diseases

As of today there are no radical methods of treatment of epidermolysis bullosa (EB) as well as other genetically determined diseases. This accounts for the acuteness of the problem of providing adequate care for such patients. The Georgian Foundation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e445d66bdd4a83cca0c2b83b20daf3db
https://doi.org/10.1186/1750-1172-5-s1-p28

P3.083 Is the Syphilis Incidence Decreasing in Georgia?

Autor: O Kvlividze, Marius Domeika, Magnus Unemo, George Galdava

Publikováno v: Sexually Transmitted Infections. 89:A173.4-A174

Background The epidemiology of syphilis in Georgia has traditionally been determined by socio-economic factors such as low solvency of Georgian population, urban migration, level of financing of STI prevention programmes etc. This study reports on th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e09289efe5e2cd56d773676ff1ccf0d
https://doi.org/10.1136/sextrans-2013-051184.0543